Dacarbazine and thrombocytopenia Patient Reports February 11, 2012

Dacarbazine Side Effects Report #5451039-9
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Male patient, 41 years of age, weighting 209.4 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: leukopenia, pyrexia, thrombocytopenia. Dacarbazine dosage: 2260MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4760936-9
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 26, 2005. Female patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haematuria, haemoglobin decreased, nausea , overdose, pyrexia, thrombocytopenia. Dacarbazine dosage: unknown. During the same period patient was treated with GENASENSE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4767994-6
Dacarbazine side effect was reported by a Physician from UNITED STATES on Aug 30, 2005. Female patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: haematuria, nausea , overdose, pyrexia, thrombocytopenia. Dacarbazine dosage: unknown. During the same period patient was treated with GENASENSE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5034676-5
Dacarbazine side effect was reported by a Physician from AUSTRALIA on June 12, 2006. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia. Dacarbazine dosage: 1400 MG DAILY IV. During the same period patient was treated with BOSENTAN, IRBESARTAN, ASPIRIN, COLOXYL WITH SENNA. Patient recovered.


Dacarbazine Side Effects Report #4875676-5
Dacarbazine side effect was reported by a Physician from AUSTRALIA on Dec 23, 2005. Male patient, 76 years of age, weighting 152.1 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia. Dacarbazine dosage: 1780 MG DAILY IV. During the same period patient was treated with BOSENTAN, FRUSEMIDE, POTASSIUM CHLORIDE, WARFARIN, CARVEDILOL, TRANDOLAPRIL. Patient recovered.

Dacarbazine Side Effects Report #4939221-8
Dacarbazine side effect was reported by a Physician from AUSTRALIA on Feb 21, 2006. Male patient, 76 years of age, weighting 152.1 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: arrhythmia , cardiac fibrillation, neutropenia, thrombocytopenia. Dacarbazine dosage: 1780 MG DAILY IV. During the same period patient was treated with BOSENTAN, FRUSEMIDE, POTASSIUM CHLORIDE, WARFARIN, CARVEDILOL, TRANDOLAPRIL. Patient recovered.

Dacarbazine Side Effects Report #5950408-8
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 04, 2008. Female patient, 73 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaemia, localised infection, neutropenia, thrombocytopenia. Dacarbazine dosage: TOTAL DAILY DOSE: 2000 MG. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4678445-4
Dacarbazine side effect was reported by a Health Professional from on May 31, 2005. Male patient, 65 years of age, weighting 228.0 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: febrile neutropenia, thrombocytopenia. Dacarbazine dosage: 2160 MG IV. During the same period patient was treated with TOPROL, LOTENSIN, HYDROCHLOROTHIAZIDE, PACERONE, ASPIRIN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5524592-4
Dacarbazine side effect was reported by a Physician from UNITED STATES on Nov 19, 2007. Female patient, 62 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, thrombocytopenia. Dacarbazine dosage: unknown. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5386541-1
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Female patient, 47 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia. Dacarbazine dosage: unknown. During the same period patient was treated with GRANISETRON, DOMPERIDONE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5939954-0
Dacarbazine side effect was reported by a Physician from UNITED STATES on Oct 31, 2008. Female patient, weighting 180.8 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaemia, disease progression, neutrophil count abnormal, thrombocytopenia. Dacarbazine dosage: 1500MG IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6003219-1
Dacarbazine side effect was reported by a Physician from UNITED STATES on Dec 15, 2008. Male patient, weighting 193.3 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: cardiac failure congestive, febrile neutropenia, thrombocytopenia. Dacarbazine dosage: unknown. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.